These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 12389993)
1. Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas. Ondruschka C; Buhtz P; Motsch C; Freigang B; Schneider-Stock R; Roessner A; Boltze C Pathol Res Pract; 2002; 198(8):509-15. PubMed ID: 12389993 [TBL] [Abstract][Full Text] [Related]
2. Elevated expression of MMP-13 and TIMP-1 in head and neck squamous cell carcinomas may reflect increased tumor invasiveness. Culhaci N; Metin K; Copcu E; Dikicioglu E BMC Cancer; 2004 Aug; 4():42. PubMed ID: 15291964 [TBL] [Abstract][Full Text] [Related]
3. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas]. Wei QY; Wu YQ; Fan SQ Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069 [TBL] [Abstract][Full Text] [Related]
4. Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas. Görögh T; Beier UH; Bäumken J; Meyer JE; Hoffmann M; Gottschlich S; Maune S Head Neck; 2006 Jan; 28(1):31-9. PubMed ID: 16265652 [TBL] [Abstract][Full Text] [Related]
5. Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2--complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma. Hoikkala S; Pääkkö P; Soini Y; Mäkitaro R; Kinnula V; Turpeenniemi-Hujanen T Cancer Lett; 2006 May; 236(1):125-32. PubMed ID: 15982804 [TBL] [Abstract][Full Text] [Related]
6. Increased matrix metalloproteinases 2 and 9 and tissue inhibitor of matrix metalloproteinase 2 expression is associated with progression from vulvar intraepithelial neoplasia to invasive carcinoma. Määttä M; Santala M; Soini Y; Turpeenniemi-Hujanen T; Talvensaari-Mattila A Acta Obstet Gynecol Scand; 2010 Mar; 89(3):380-4. PubMed ID: 20109015 [TBL] [Abstract][Full Text] [Related]
7. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer]. Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459 [TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K; Shigemasa K; Nagai N; Ohama K Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877 [TBL] [Abstract][Full Text] [Related]
9. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix]. Zhou CY; Yao JF; Chen XD Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097 [TBL] [Abstract][Full Text] [Related]
10. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent. Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 is correlated with poor prognostic variables in patients with thymic epithelial tumors. Sogawa K; Kondo K; Fujino H; Takahashi Y; Miyoshi T; Sakiyama S; Mukai K; Monden Y Cancer; 2003 Nov; 98(9):1822-9. PubMed ID: 14584061 [TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of matrix metalloproteinase and tissue inhibitor of metalloproteinase in nasal cavity squamous cell carcinoma]. Zheng Y; Ding J; Wang CL; Jiao SS; Qu LM; Bahargul ; Bao H; Chen X Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Apr; 46(4):299-302. PubMed ID: 21624249 [TBL] [Abstract][Full Text] [Related]
13. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein. Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T Clin Cancer Res; 2005 May; 11(9):3257-64. PubMed ID: 15867221 [TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma]. Fan SQ; Wei QY; Li MR; Zhang LQ; Liang QC Ai Zheng; 2003 Sep; 22(9):968-73. PubMed ID: 12969531 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer. Sharma R; Chattopadhyay TK; Mathur M; Ralhan R Oncology; 2004; 67(3-4):300-9. PubMed ID: 15557792 [TBL] [Abstract][Full Text] [Related]
16. Plasma level of tissue inhibitor of matrix metalloproteinase-1 but not that of matrix metalloproteinase-8 predicts survival in head and neck squamous cell cancer. Pradhan-Palikhe P; Vesterinen T; Tarkkanen J; Leivo I; Sorsa T; Salo T; Mattila PS Oral Oncol; 2010 Jul; 46(7):514-8. PubMed ID: 20371206 [TBL] [Abstract][Full Text] [Related]
17. Immunoexpression and prognostic significance of TIMP-1 and -2 in oral squamous cell carcinoma. de Vicente JC; Fresno MF; Villalain L; Vega JA; López Arranz JS Oral Oncol; 2005 Jul; 41(6):568-79. PubMed ID: 15925538 [TBL] [Abstract][Full Text] [Related]
18. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker. Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441 [TBL] [Abstract][Full Text] [Related]
19. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas. Zhang YG; DU J; Tian XX; Zhong YF; Fang WG Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479 [TBL] [Abstract][Full Text] [Related]
20. Imbalance between Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Promotes Invasion and Metastasis of Head and Neck Squamous Cell Carcinoma. Stanciu AE; Zamfir-Chiru-Anton A; Stanciu MM; Popescu CR; Gheorghe DC Clin Lab; 2017 Oct; 63(10):1613-1620. PubMed ID: 29035450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]